Abciximab or eptifibatide: Differences in outcomes of patients treated with abciximab versus eptifibatide as adjunct therapy for primary percutaneous coronary interventions for ST elevation myocardial infarction.

被引：0
|
作者：
Hitinder, Gurm [1 ]
Share, David [1 ]
Smith, Dean E. [1 ]
LaLonde, Thomas [1 ]
O'Donnell, Michael [1 ]
Riba, Arthur [1 ]
Changezi, Hameem [1 ]
Zughaib, Marcel [1 ]
Chandra, Harish [1 ]
Safian, Robert [1 ]
Moscucci, Mauro [1 ]
机构：
[1] Univ Michigan, Med Ctr, Ann Arbor, MI 48109 USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2007年 / 49卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：292A / 292A
页数：1
相关论文
共 50 条
  • [41] The impact of renal failure and adjunctive eptifibatide therapy on bleeding risk in patients treated with primary percutaneous coronary intervention for acute myocardial infarction
    Assali, Abid
    Ben-Dor, Itsik
    Lev, Eli
    Vaknin-Assa, Hana
    Fuchs, Shmuel
    Battler, Alexander
    Kornowski, Ran
    CARDIOVASCULAR DRUGS AND THERAPY, 2007, 21 : S19 - S19
  • [42] Comparison Of Safety and Efficacy Of Intracoronary Bolus Abciximab Only Versus Standard Intravenous Bolus and Infusion Abciximab In Patients With Acute ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention
    Hung M Ngo
    Tan, Cheem Huay
    AMERICAN JOURNAL OF CARDIOLOGY, 2009, 104 (6A): : 4D - 4D
  • [43] Two-Year Clinical Follow-up Comparing Eptifibatide and Abciximab in Patients Undergoing Primary Percutaneous Revascularization for ST-Elevation Myocardial Infarction Results from the HORIZONS-AMI Trial
    Singh, Harsimran S.
    Mehran, Roxana
    Stone, Gregg W.
    Dangas, George D.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2010, 56 (13) : B20 - B20
  • [44] Comparison of outcomes between patients undergoing percutaneous coronary stent implantation with eptifibatide and abciximab: An analysis using propensity score methods
    Dery, Jean-Pierre
    Griffin, Jeffrey
    Pieper, Karen S.
    Harrington, Robert A.
    Tcheng, James E.
    AMERICAN JOURNAL OF CARDIOLOGY, 2007, 100 (8A): : 41L - 42L
  • [45] One year outcomes with abciximab and unfractionated heparin vs. bivalirudin during Percutaneous Coronary Interventions in patients with non-ST-Segment Elevation Myocardial Infarction
    Schulz, S.
    Kastrati, A.
    Ferenc, M.
    Massberg, S.
    Laugwitz, K. -L.
    Gick, M.
    Schuhlen, H.
    Schomig, A.
    Mehilli, J.
    Neumann, F. -J.
    EUROPEAN HEART JOURNAL, 2012, 33 : 549 - 549
  • [46] Beneficial effects of abciximab in patients with primary percutaneous intervention for acute ST segment elevation myocardial infarction in clinical practice
    Heer, T.
    Zeymer, U.
    Juenger, C.
    Gitt, A. K.
    Wienbergen, H.
    Zahn, R.
    Gottwik, M.
    Senges, J.
    HEART, 2006, 92 (10) : 1484 - 1489
  • [47] Therapeutic window in early abciximab administration in ST-elevation myocardial infarction during transfer for primary percutaneous coronary intervention
    Bastos Fernandez, G.
    Jimenez Diaz, V. A.
    De Miguel Castro, A. A.
    Paredes Galan, E.
    Ortiz Saez, A.
    Gomez Blazquez, I.
    Villanueva Benito, I.
    Baz Alonso, J. A.
    Iniguez Romo, A.
    EUROPEAN HEART JOURNAL, 2011, 32 : 419 - 419
  • [48] Optimal reperfusion in evolving myocardial infarction. Does abciximab improve outcomes in stent treated patients?
    Masotti, M
    Betriu, A
    EUROPEAN HEART JOURNAL, 2001, 22 : 475 - 475
  • [49] SEX DIFFERENCES IN OUTCOMES OF PATIENTS UNDERGOING PRIMARY PERCUTANEOUS CORONARY INTERVENTION WITH ST ELEVATION MYOCARDIAL INFARCTION
    Liu, ChuanFen
    Wang WeiMin
    HEART, 2013, 99 : E165 - E166
  • [50] Early abciximab administration before primary percutaneous coronary intervention improves clinical outcome in elderly patients with ST-elevation myocardial infarction
    Dziewierz, A.
    Siudak, Z.
    Rakowski, T.
    Mielecki, W.
    Chyrchel, M.
    Dubiel, J. S.
    Dudek, D.
    EUROPEAN HEART JOURNAL, 2008, 29 : 571 - 571
12345